Fusion Antibodies PLC
LSE:FAB
Fusion Antibodies PLC
LSE:FAB
Price:
3.4 GBX
Updated:
May 14, 2024
Fusion Antibodies PLC
Retained Earnings
|
Fusion Antibodies PLC
Retained Earnings Peer Comparison
Comparables:
ONT
O
ORPH
DXRX
ERGO
HVO
Competitive Retained Earnings Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Retained Earnings | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Fusion Antibodies PLC
LSE:FAB
|
Retained Earnings
-£8.9m
|
CAGR 3-Years
-96%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Oxford Nanopore Technologies PLC
LSE:ONT
|
Retained Earnings
-£54.6m
|
CAGR 3-Years
49%
|
CAGR 5-Years
29%
|
CAGR 10-Years
N/A
|
|
O
|
Open Orphan PLC
LSE:ORPH
|
Retained Earnings
£18.2m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Diaceutics PLC
LSE:DXRX
|
Retained Earnings
£5.3m
|
CAGR 3-Years
27%
|
CAGR 5-Years
27%
|
CAGR 10-Years
N/A
|
|
|
Ergomed PLC
LSE:ERGO
|
Retained Earnings
£88.5m
|
CAGR 3-Years
81%
|
CAGR 5-Years
59%
|
CAGR 10-Years
N/A
|
|
|
hVIVO PLC
LSE:HVO
|
Retained Earnings
£31.8m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Fusion Antibodies PLC's Retained Earnings?
Retained Earnings
-8.9m
GBP
-8.9m
GBP
Based on the financial report for Sep 30, 2023, Fusion Antibodies PLC's Retained Earnings amounts to -8.9m GBP.
What is Fusion Antibodies PLC's Retained Earnings growth rate?
Retained Earnings CAGR 3Y
-96%
-96%
Over the last year, the Retained Earnings growth was -46%. The average annual Retained Earnings growth rates for Fusion Antibodies PLC have been -96% over the past three years .
You don't have any saved screeners yet
